Meeting
2021 Gastrointestinal Cancers Symposium
Familial pancreatic cancer (FPC) status as a clinical biomarker in patients receiving platinum-based systemic therapy: A case-control analysis.
Authors
Deirdre Kelly
Princess Margaret Cancer Center, Toronto, ON, Canada
Deirdre Kelly , Ayelet Borgida , Sheron Perera , Robert Edward Denroche , Spring Holter , Zhihui (Amy) Liu , Zijin Liu , Amy Zhang , Anna Dodd , Stephanie Ramotar , Shawn Hutchinson , Julie Wilson , Faiyaz Notta , Jennifer J. Knox , Steven Gallinger , Robert C Grant , Grainne M. O'Kane
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Pancreatic Cancer
Track
Pancreatic Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 430)
DOI
10.1200/JCO.2021.39.3_suppl.430
Abstract #
430
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Elevated pretreatment serum IL-8 and PD-L1 and overall survival in a phase III randomized advanced pancreatic cancer clinical trial.
First Author: Ashok Maddukuri
Poster
2024 ASCO Annual Meeting
Differences in baseline characteristics and healthcare costs among insured patients with advanced cancer with vs without clinical trial participation.
First Author: Karen M Stockl
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Advanced pancreatic cancer outcomes and the impact of COVID-19 pandemic: The experience of an academic cancer center.
First Author: Christian Adams-Carey
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The prognostic value of mutational signatures in pancreatic cancer.
First Author: Nicholas Light